Case Report
Published on 27 Jul 2023
Larotrectinib treatment for infantile fibrosarcoma in newborns: a case report and literature review
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1206833
- 1,721 views
Type at least 3 characters
1,765 articles
Articles
Case Report
Published on 21 Jul 2023
An advanced pulmonary sarcomatoid carcinoma patient harboring a BRAFV600E mutation responds to dabrafenib and trametinib: a case report and literature review
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1220745
- 1,675 views
- 1 citation
Mini Review
Published on 21 Jul 2023
Circulating circRNA: a social butterfly in tumors
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1203696
- 2,093 views
- 4 citations
Case Report
Published on 11 Jul 2023
Case Report: A rare synchronous multiple gastric carcinoma achieved progression-free disease through NGS-guided serial treatment
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1195837
- 1,509 views
Brief Research Report
Published on 10 Jul 2023
MACC1 and MET as markers associated with progression and metastasis in cutaneous melanoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1146092
- 1,112 views
Editorial
Published on 07 Jul 2023
Editorial: Women in cancer molecular targets and therapeutics, volume II: 2022
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1241793
- 1,219 views
Original Research
Published on 07 Jul 2023
Cystathionine β-synthase affects organization of cytoskeleton and modulates carcinogenesis in colorectal carcinoma cells
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1178021
- 2,344 views
- 1 citation
Editorial
Published on 07 Jul 2023
Editorial: Patient-derived tumor models for drug development
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1243534
- 1,655 views
- 1 citation
Original Research
Published on 05 Jul 2023
Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1213426
- 3,092 views
- 5 citations
Original Research
Published on 04 Jul 2023
Manipulating RKIP reverses the metastatic potential of breast cancer cells
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1189350
- 1,613 views
- 3 citations
Brief Research Report
Published on 03 Jul 2023
Genomic determinants in advanced endometrial cancer patients with sustained response to hormonal therapy- case series and review of literature
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1188028
- 1,830 views
Review
Published on 03 Jul 2023
T-cell redirecting therapies for B-cell non-Hodgkin lymphoma: recent progress and future directions
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1168622
- 8,957 views
- 4 citations
Review
Published on 30 Jun 2023
Paper-based biosensors as point-of-care diagnostic devices for the detection of cancers: a review of innovative techniques and clinical applications
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1131435
- 4,190 views
- 8 citations
Correction
Published on 27 Jun 2023
Corrigendum: Advanced NSCLC patients with EGFR T790M harbouring TP53 R273C or KRAS G12V cannot benefit from osimertinib based on a clinical multicentre study by tissue and liquid biopsy
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1236311
- 1,075 views
Correction
Published on 27 Jun 2023
Corrigendum: High expression of PARP1 in tumor and stroma cells predicts prognosis and platinum resistance in patients with advanced epithelial ovarian cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1218746
- 886 views
Original Research
Published on 23 Jun 2023
An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1207068
- 4,505 views
- 10 citations